Main > DERMATOLOGY > Psoriasis>Plaque Psoriasis (**) > Treatment > Co: UK. A. BrodaluMAb Inj. *

---

Co: UK. A. BrodaluMAb Inj. *'s subsections
(*) EU Approval Date: 2017. 07.20
(*) JP Approval Date: 2016. 07.
(*) USA Approval Date: 2017. 02.16
(*) USA Launch Date: 2017. 07.27
Company
EU Licensee:
IL-17 Receptor AntAgonist
JP Licensee:
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2017. 02.14.
TradeMark (EU)
TradeMark (JP)
TradeMark (USA)
TradeMark (USA) Web-Site
USA Licencee:

Co: UK. A. BrodaluMAb Inj. *'s products
This section has no products